The oncogenic role of MAML2 was first described in mucoepidermoid carcinoma, in which a fusion oncogene MECT1-MAML2 that was involved in disrupting the normal cell cycle, differentiation and tumor development [21]. Here, CRTC1 is linked to neoplasm.